Trial Profile
Phase I Study of FK949E - Multiple Dose Study of Non-Elderly Adult Patients With Major Depressive Disorder (MDD)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 12 Jun 2013 New trial record